Topical ReviewAutism Spectrum Disorders and Inborn Errors of Metabolism: An Update
Introduction
Autism spectrum disorder (ASD) is a behavioral syndrome characterized by social communication deficits with rigid restricted interests, occurring in about 1% of the population.1, 2 Although ASD and autism are often used interchangeably, the former more correctly refers to a group of disorders of varying degrees of severity. At least 10% of patients with ASD suffer from comorbid disorders, such as tuberous sclerosis and fragile X syndrome.3
ASD can also occur with inborn errors of metabolism, sometimes referred to as inherited metabolic disorders, which occur in 1 in 800 live births.4 These conditions, which have become increasingly important because of the progress made in their diagnosis and management,5 occur when an enzyme or a transport protein deficiency causes a block in a metabolic pathway resulting either in a harmful accumulation of the substrate behind the block or in a deficiency of the product. They can be divided into acute and chronic categories. The former group usually begins in the first 2-3 years of life and may present in metabolic crisis (intoxication), whereas the latter may come to medical attention at any time and have a more insidious course. Metabolic disorders with intoxication often present with acute encephalopathy associated with acidosis, hyperammonemia, and/or hypoglycemia.5 Several behavioral and neuropsychiatric abnormalities can occur in children with metabolic disorders.6 These stem from the involvement of the central nervous system and include learning disability, social deficits, hyperactivity, aggression, catatonia, psychosis, and depression.7 Because most metabolic disorders are autosomal recessive,8 they are more common in countries with high rates of consanguinity, where they are associated with a significant degree of morbidity and mortality.9
Increased awareness of both autism and of inherited metabolic disorders has increased the focus on the comorbidity between them. Although, the exact rate of autism in patients with inherited metabolic disorders is not known, the rate of the latter in patients with autism is said to be around 2%. For example, in a study of 222 Greek children with autism, 2.7% suffered from a metabolic disorder.10 However, given that the correct diagnosis of an inborn error of metabolism requires both clinical and technological expertise, this figure is probably closer to 5%.11
There have been no recent reviews of the association of autism with metabolic disorders since the last review by Manzi and colleagues.12 Since then, several new reports have described the occurrence of autism in patients with inherited metabolic disorders. For example, a novel metabolic entity (branched chain ketoacid dehydrogenase kinase deficiency) was recently described in multiple consanguineous families with autism, epilepsy, and intellectual disability.13 The aim of this review is to describe the association between the two conditions with particular reference to publications since the review by Manzi et al.12
Section snippets
Method
A computer-assisted PubMed search was performed with the keywords “autism,” “autism spectrum disorders,” “pervasive developmental disorders,” “metabolic diseases,” “metabolic disorders,” and “inborn errors of metabolism.” Through cross-references, reviews and book chapters were also examined. The following disorders were most commonly identified.
Assessment and treatment
Clinicians working in countries with a high prevalence of recessive conditions should rule out autism in patients with inborn errors of metabolism, especially in children with behavioral problems. Common behavioral problems that suggest a need for screening for autism include speech and language abnormalities, hyperactivity and impulsivity, difficulty in interacting with peers, suggestion of intellectual disability, and presence of excessive interests and ritualistic behaviors. There is a
Conclusion
Autistic symptoms occur in a variety of inborn errors of metabolism. These are more likely to occur in certain countries, such as in the Middle East, where recessive conditions are common because of consanguinity. The association of autism with metabolic disorders underscores that autism can be the end result of a variety of insults and injuries. The severity of the autistic symptoms varies with the timing of the diagnosis and the subsequent treatment, as in the case of phenylketonuria.
References (58)
- et al.
Autism spectrum disorders: clinical features and diagnosis
Pediatr Clin N Am
(2012) - et al.
Experience of King Faisal Specialist Hospital and Research Center with Saudi organic acid disorders
Brain Dev
(1994) - et al.
Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders
Behav Brain Res
(2007) - et al.
Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder
Behav Brain Res
(2011) - et al.
Outcome of infants diagnosed with 3-methyl-crotonyl-CoA-carboxylase deficiency by newborn screening
Mol Genet Metab
(2012) - et al.
Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up
Mol Genet Metab
(2011) - et al.
Autism and adenylosuccinase deficiency
J Am Acad Child Adolesc Psychiatry
(2000) - et al.
Adenosine deaminase activity decreased in autism
J Am Acad Child Adolesc Psychiatry
(1982) Disorders of purine and pyrimidine metabolism
Mol Genet Metab
(2005)Biotinidase deficiency
Genet Med
(2012)
Cerebral folate deficiency: a neurometabolic syndrome?
Mol Genet Metab
Creatine and creatine deficiency syndromes: biochemical and clinical aspects
Pediatr Neurol
Review of the literature on major mental disorders in adult patients with mitochondrial diseases
Psychosomatics
Glucose-6-phosphate dehydrogenase deficiency
Lancet
Inborn errors of cholesterol biosynthesis
Adv Pediatr
Autistic disturbances of affective contact
Nervous Child
Autism and known medical conditions: myth and substance
J Child Psychol Psychiatry
Inherited metabolic rare disease
Adv Exp Med Biol
Clinical approach to treatable inborn metabolic diseases: an introduction
J Inherit Metab Dis
Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults
J Inherit Metab Dis
Psychiatric symptoms of inherited metabolic disease
J Inherit Metab Dis
Neurometabolic disorders and dysfunction in autism spectrum disorders
Curr Neurol Neurosci Rep
Map of autosomal recessive genetic disorders in Saudi Arabia: concepts and future directions
Am J Med Genet A
Clinical and laboratory data in a sample of Greek children with autism spectrum disorders
J Autism Dev Disord
Medical conditions associated with autism
Autism and metabolic diseases
J Child Neurol
Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy
Science
Phenylalanine hydroxylase deficiency
A Chinese classic phenylketonuria manifested as autism
Br J Psychiatry
Cited by (49)
Neurological evaluation and management of autism spectrum disorder
2020, Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease: Volume 1Genetic mechanisms of regression in autism spectrum disorder
2019, Neuroscience and Biobehavioral ReviewsCitation Excerpt :However, inborn errors of metabolism, such as those leading to biological pathway dysfunctions within cellular organelles – mitochondria, peroxisomes, lysosomes – or to defective energy source metabolism – lipids, proteins, carbohydrates – should be considered potential causes of unexpected regression (Rice and Steiner, 2016). These genetic disorders are not covered by this review but their connection to ASD has been summarized elsewhere (Ghaziuddin and Al-Owain, 2013). This review aims to describe the evidence for genetic influences in regressive ASD and summarize the rates of the regression phenotype within carriers of ASD-associated gene variants.
Co-occurrence of delayed language development and autism spectrum disorder in children with metabolic disorders
2024, Egyptian Journal of Otolaryngology